MedPath

Role of diet, exercise and bariatric surgery in weight loss management.

Not Applicable
Conditions
Health Condition 1: E662- Morbid (severe) obesity with alveolar hypoventilationHealth Condition 2: null- Obesity and associated comorbidities
Registration Number
CTRI/2018/06/014409
Lead Sponsor
Prof Sandeep Aggrawal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Inclusion Criteria for first cohort (Group I):

a) Adult aged between 18-65 yrs

b) BMI 25-29.9 kg/m2

Inclusion Criteria for second cohort (GroupII):

a)Adult aged between 18-65 yrs

b)Normal adult BMI >29.9 kg/m2 to 34.9 kg/m2

Inclusion criteria for nonsurgical intervention in morbidly obese group:

a)BMI >=35 kg/m2

b)Adult aged between 18-65 yrs

Inclusion criteria for surgical intervention in

morbidly obese group:

a)Adult aged between 18-65 yrs

b)BMI >=35 kg/m2 with co-morbidities or BMI >=40 kg/m2

c)All non surgical measures have been tried but have failed to achieve or maintain adequate, clinically beneficial weight loss for at least 6 month

d)Patient with no psychological or clinical contraindications to anesthesia or surgery

e)Patient who have comprehension and commitment to long term follow up

Exclusion Criteria

Exclusion Criteria for first cohort (Group I):

1)Age below 18 yrs and above 65yrs

2)BMI >29.9kg/m2

3)Pregnant or lactating mothers

4)Acute or severe chronic illness or severe end organ damage

5)Patient is on some drug/s which can lead to hyperglycemia

6)Secondary cause of obesity: any endocrinological dysfunction, drug intake

7)Patient who refuse consent for the study

Exclusion Criteria for second cohort (Group II)

1)Age below 18 yrs and above 65yrs

2)BMI >=35kg/m2

3)Pregnant or lactating mothers

4)Acute or severe chronic illness or severe end organ damage

5)Patient is on some drug/s which can lead hyperglycemia

6)Secondary cause of obesity: any endocrinological dysfunction, drug intake

7)Patient who refuse consent for the study

Exclusion criteria for nonsurgical intervention in morbidly obese group:

1)BMI <35 kg/m2

2)Age below 18 yrs and above 65yrs

3)Pregnant or lactating mothers

4)Acute or severe chronic illness or severe end organ damage

5)Patient is on some drug/s which can lead hyperglycemia

6)Secondary cause of obesity: any endocrinological dysfunction, drug intake

7)Patient who refuse consent for the study

Exclusion criteria for surgical intervention for morbidly obese group:

1)Age below 18 yrs and above 65yrs

2)BMI >=35 kg/m2 without co-morbidities or BMI <40 kg/m2

3)Pregnant or lactating mothers

4)Young female patients who have plan to extend family in next 2 years

5)Acute or severe chronic illness or severe end organ damage

6)Patient is on some drug/s which can lead hyperglycemia

7)Secondary cause of obesity: any endocrinological dysfunction, drug intake

8)Patient who are high risk for surgery

9)Patient who refuse consent for the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath